Clinical Trial Update: AST-120 in Hemodialysis Patients With Uremic Pruritus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for AST-120 in hemodialysis patients with uremic pruritus has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uremic Pruritus

Drugs mentioned

• AST-120 (AST-120)

Snippet

Sponsor: Conmed Pharmaceutical & Bio-Medical Corporation | Conditions: Uremic Pruritus | Phase 4 | Status: COMPLETED